Together involves a continuous glucose monitoring device, Covering a wide range of patent disputes, The British High Court did not support Abbott Laboratories (Abbott) Right, Dekang Medical (Dexcom) A claim for infringement filed. Given the huge market value of the patents involved, The debate will continue at the European Patent Office (EPO) , Unitary patent court (UPC) , Germany and the United States and other places.

As mentioned above, Dekang Medical and Abbott Laboratories are currently going head-to-head over multiple patents involving continuous glucose monitoring devices, And the dispute has spread to several countries, That includes the U. K, Germany and the US.

concretely, In an action for invalidity and infringement brought in the UK, In total17A patent has put forward its own claim. Up to now, The court has already heard some of them3A case, And will be in2024years11Tsukiwa2025years1Month to hear another2A case. According to the International Diabetes Federation, Around the world5. 4Hundreds of millions of people have diabetes. therefore, The market is huge, The value of connected medical devices involving blood sugar monitoring will only continue to grow.

Abbott sued for infringement

The trial involved Abbott's NoEP2549918Patent No. As a patent owner, The company accused Dekang Medical "G7 Applicator" The equipment infringes its patent rights, Dekang Medical filed invalid counterclaims against the patents involved.

merely, The high court rejected Abbott's claims of infringement, At the same time, the patent is found to be valid. 2022Autumn of next year, EPOThe Appeal Board also considers that the revised NoEP2549918Patent No. 1 is valid.

People with diabetes can monitor glucose levels in their blood using continuous glucose monitoring technology. This is done by inserting a tiny sensor under the skin, The sensor is part of a wearable device that attaches to the skin. Sensors measure glucose concentrations in the surrounding tissue, And transmit the information to the receiver (Such as smart phones) Up, This allows users to easily see if their blood sugar is in the normal range.

Dekang Medical is inUPCFile a lawsuit

Given the growing market value of the device, The two companies are in national courts, EPOOffice sumUPCThere was a fierce struggle between the two sides. Such as, 2022years, The Mannheim District Court dismissed Abbott's lawsuit against Decon Medical.

At the same time, Dekang Medical was thereUPCThe local branch in Munich and the local branch in Paris as to what they own4Pieces of patent (The numbers are respectivelyEP3831282, EP3797685, EP4111949andEP3435866) Filed a lawsuit. (Be compiled fromwww. juve-patent. com)

TRANSLATORS: Liu Peng　proofread: Wang Dan

　　disclaimer: This network reprint or compile the original articles are from the network, Does not represent the views of this website or confirm the authenticity of its content. If the source is mislabeled or the copyright of the article is involved, Please contact us, This website will be corrected in due course, delete, thank you.